Enhancing the efficacy of antidepressants with psychotherapy

@article{Petersen2006EnhancingTE,
  title={Enhancing the efficacy of antidepressants with psychotherapy},
  author={Timothy J. Petersen},
  journal={Journal of Psychopharmacology},
  year={2006},
  volume={20},
  pages={19 - 28}
}
  • T. Petersen
  • Published 2006
  • Psychology, Medicine
  • Journal of Psychopharmacology
Even after optimal treatment with and response to antidepressant medications during acute treatment of major depressive disorder, residual symptoms are common. Patients with residual symptoms are at increased risk of relapse and recurrence. Research suggests that psychotherapy may play an important role in enhancing the effects of antidepressant drug therapy and improving patients' long-term prognosis. Psychotherapy targets specific symptoms associated with relapse (e.g., guilt, hopelessness… Expand

Paper Mentions

Interventional Clinical Trial
The purpose of this study is to determine the level of residual symptoms and psychosocial factors affecting recovery of psychosocial functions in MDD patients who reach remission, and… Expand
ConditionsDepressive Disorder
InterventionBehavioral, Drug
Combined treatment of depression.
TLDR
There are several reasons to believe that medication and psychotherapy should be utilized together for treatment of depression, and combining two treatments increases the likelihood patients will respond to at least one of the treatments. Expand
Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination
TLDR
The results suggest that greater initial depression severity, greater difficulty in stabilizing symptoms, and presence of residual mood spectrum symptoms once remission is achieved are predictive of relapse. Expand
Residual Symptoms of Depression: Adjuvant Therapies
Residual Symptoms of Depression (SRD, in Spanish) are those that persist despite a good response to antidepressant drug treatment. They have a high incidence in the psychiatric clinic and areExpand
Antidepressants and Psychological Treatment: Hard Reasons for Synergy
Improving the efficacy of depression treatment is a clinical necessity. «Synergy» is the systematic process in which different treatments of and approaches to mood disorders are evaluated and made toExpand
The Long-Term Effects of Psychotherapy Added to Pharmacotherapy on Morning to Evening Diurnal Cortisol Patterns in Outpatients with Major Depression
TLDR
The superior outcomes of group psychotherapy added to pharmacotherapy for MDD outpatients could relate to decreasing the anxiety state and to producing long-term impacts on positive stress endocrine outcomes seen as a steeper diurnal cortisol pattern. Expand
Effect of group cognitive-behavioral therapy on the quality of life and social functioning of patients with mild depression
TLDR
Combined treatment with both antidepressants and group CBT is better than treatment with antidepressants alone, and these benefits persist for up to one year after the CBT sessions have ended. Expand
A Systematic Review of the Combined Use of Electroconvulsive Therapy and Psychotherapy for Depression
TLDR
This systematic review synthesizes extant data regarding the combined use of psychotherapy with ECT for the treatment of patients with severe major depressive disorder and offers the hypothesis that augmenting ECT with depression-specific psychotherapy represents a promising strategy for future investigation. Expand
Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: a meta-analysis.
TLDR
Patients receiving combined treatment experienced remission more often than those receiving pharmacotherapy alone, with the highest odds ratio OR, 2.36; 95% CI, 1.58-3.55 observed at 4months after commencing the treatment. Expand
The Effect of Psychotherapy Added to Pharmacotherapy on Cortisol Responses in Outpatients With Major Depressive Disorder
TLDR
It is suggested that CT produced a protective effect on outpatients with major depression, preventing the increased night salivary cortisol levels and the flatter diurnal cortisol pattern that tended to occur in MT. Expand
Improving outcomes for patients with depression by enhancing antidepressant therapy with non-pharmacological interventions: a systematic review of reviews.
TLDR
Conclusions regarding the effects of adherence-improving and multifaceted interventions are fairly certain, however, the findings about the impact of combined psychotherapy and pharmacotherapy on the outcomes of depression remain tentative due to the methodological limitations of available reviews. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 42 REFERENCES
Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression.
TLDR
Cognitive therapy may play a role in improving remission rates and decreasing relapse and recurrence rates and there is a consistent suggestion of superior prophylaxis for patients receiving some type of sequenced or crossover treatment in which the delivery of antidepressant medication and structured antidepressant psychotherapy is combined. Expand
Residual symptoms in depression An emerging therapeutic target
TLDR
The hypothesis is that residual symptoms upon recovery may progress to become prodromal symptoms of relapse, and the efficacy of antidepressant drugs may be assessed not only on differential remission rates, but also on differential amount of residual symptomatology after response. Expand
Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings.
TLDR
The results challenge the assumption that long-term drug treatment is the only tool to prevent relapse in patients with recurrent depression and suggest CBT offers a viable alternative for other patients. Expand
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
TLDR
Both medication and certain targeted psychotherapies appear to be effective in the treatment of depression. Expand
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations.
TLDR
New evidence is found in support of the widespread clinical impression that combined therapy is superior to psychotherapy alone for treatment of more severe, recurrent depressions. Expand
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
TLDR
Most patients with chronic forms of MDD sustained their acute phase response and more than 50% of partial remitters achieved full remission while continuing treatment with nefazodone, CBASP, or COMB, which was associated with less symptom re-emergence during the continuation phase than either monotherapy. Expand
Prevention of relapse in residual depression by cognitive therapy: a controlled trial.
TLDR
In this difficult-to-treat group of patients with residual depression who showed only partial response despite antidepressant treatment, cognitive therapy produced worthwhile benefit. Expand
Effects of cognitive therapy on psychological symptoms and social functioning in residual depression
TLDR
In patients showing only partial response to antidepressants, the addition of cognitive therapy produced modest improvements in social and psychological functioning. Expand
Cognitive therapy vs medications in the treatment of moderate to severe depression.
TLDR
Cognitive therapy can be as effective as medications for the initial treatment of moderate to severe major depression, but this degree of effectiveness may depend on a high level of therapist experience or expertise. Expand
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
TLDR
Cognitive therapy has an enduring effect that extends beyond the end of treatment and seems to be as effective as keeping patients on medication. Expand
...
1
2
3
4
5
...